Ilosone: Potent Macrolide Antibiotic for Bacterial Infection Resolution
Ilosone
| Product dosage: 250 mg | |||
|---|---|---|---|
| Package (num) | Per tab | Price | Buy |
| 60 | $0.97 | $58.00 (0%) | 🛒 Add to cart |
| 90 | $0.91
Best per tab | $87.00 $82.00 (6%) | 🛒 Add to cart |
| Product dosage: 500 mg | |||
|---|---|---|---|
| Package (num) | Per tab | Price | Buy |
| 30 | $1.80 | $54.00 (0%) | 🛒 Add to cart |
| 60 | $1.62 | $108.00 $97.00 (10%) | 🛒 Add to cart |
| 90 | $1.37
Best per tab | $162.00 $123.00 (24%) | 🛒 Add to cart |
Synonyms | |||
Ilosone (erythromycin estolate) is a well-established macrolide antibiotic indicated for the treatment of a wide range of bacterial infections. With a robust history of clinical use, it functions by inhibiting bacterial protein synthesis, effectively halting the growth and proliferation of susceptible organisms. This oral formulation is particularly valued for its bioavailability and tissue penetration, making it a reliable choice in both outpatient and inpatient settings. Healthcare professionals prescribe Ilosone for its efficacy against respiratory, skin, and soft tissue infections, among others.
Features
- Active ingredient: Erythromycin estolate
- Available in 250 mg and 500 mg oral tablets, and oral suspension
- Macrolide antibiotic class
- Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit
- Effective against Gram-positive and some Gram-negative bacteria, as well as atypical pathogens
- Bioavailability enhanced by estolate ester formulation
Benefits
- Effectively treats respiratory tract infections, including pneumonia, bronchitis, and pertussis
- Provides reliable coverage for skin and soft tissue infections caused by susceptible organisms
- Suitable for patients with penicillin allergies, serving as an alternative therapeutic option
- Demonstrates good tissue penetration, reaching therapeutic concentrations at infection sites
- Oral formulation supports outpatient management and adherence to treatment regimens
- Established safety and efficacy profile backed by decades of clinical use
Common use
Ilosone is commonly prescribed for bacterial infections such as pharyngitis, tonsillitis, acute otitis media, respiratory tract infections (including community-acquired pneumonia), skin and soft tissue infections (e.g., erysipelas, impetigo), and pertussis (whooping cough). It is also used for prophylaxis against rheumatic fever in penicillin-allergic individuals and for the treatment of diphtheria, chlamydial infections, and Legionnaires’ disease. Off-label uses may include acne vulgaris and Helicobacter pylori eradication in combination therapy, though these are not primary indications.
Dosage and direction
Dosage must be individualized based on the type and severity of infection, patient age, renal function, and clinical response. For adults, the typical dosage is 250 mg to 500 mg every 6 hours, or 500 mg to 1 g every 12 hours. For severe infections, doses up to 4 g per day may be used. For children, the dosage is typically 30–50 mg/kg/day divided into 3–4 doses. Ilosone should be taken on an empty stomach (1 hour before or 2 hours after meals) to maximize absorption, though gastrointestinal upset may necessitate administration with food. The duration of therapy usually ranges from 7 to 14 days, depending on the infection. Complete the full course of therapy even if symptoms improve earlier.
Precautions
Use Ilosone with caution in patients with hepatic impairment, as erythromycin is primarily metabolized by the liver and may exacerbate pre-existing liver conditions. Monitor liver function tests during prolonged therapy. Caution is advised in patients with renal impairment; dosage adjustment may be necessary. Ilosone may prolong the QT interval; avoid use in patients with known QT prolongation, arrhythmias, or those taking other QT-prolonging drugs. Use during pregnancy only if clearly needed (Category B). Erythromycin is excreted in breast milk; weigh benefits against risks during lactation. Superinfection with nonsusceptible organisms, including fungi, may occur.
Contraindications
Ilosone is contraindicated in patients with known hypersensitivity to erythromycin or any macrolide antibiotics. It should not be used in patients with pre-existing liver disease or a history of hepatitis associated with erythromycin use. Concomitant use with ergot derivatives, terfenadine, astemizole, cisapride, or pimozide is contraindicated due to the risk of serious cardiac arrhythmias. Avoid use in patients with diagnosed QT prolongation or those taking medications that significantly inhibit CYP3A4.
Possible side effect
Common side effects include nausea, vomiting, abdominal pain, diarrhea, and loss of appetite. Less frequently, patients may experience allergic reactions such as rash, urticaria, or eosinophilia. Hepatotoxicity, including elevated liver enzymes, cholestatic jaundice, and hepatitis, has been reported, particularly with the estolate salt. Other potential adverse effects include QT prolongation, tinnitus, reversible hearing loss (especially at high doses), and pseudomembranous colitis. Superinfections with resistant bacteria or Candida may occur.
Drug interaction
Ilosone interacts with numerous drugs due to its inhibition of CYP3A4. It may increase levels of carbamazepine, cyclosporine, digoxin, theophylline, warfarin (monitor INR), and statins (e.g., simvastatin, increasing risk of myopathy). Concurrent use with QT-prolonging agents (e.g., antipsychotics, antiarrhythmics) increases arrhythmia risk. It may reduce efficacy of oral contraceptives; advise alternative contraception. Avoid with ergot alkaloids, terfenadine, astemizole, cisapride, or pimozide. Coadministration with clindamycin or chloramphenicol may antagonize antibacterial effects.
Missed dose
If a dose is missed, take it as soon as remembered, unless it is almost time for the next dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Maintaining consistent antibiotic levels is important for efficacy, but occasional missed doses are unlikely to significantly impact treatment outcomes if the regimen is promptly resumed.
Overdose
Symptoms of overdose may include severe nausea, vomiting, diarrhea, and abdominal cramps. Hepatotoxicity and reversible hearing loss are possible with large overdoses. QT prolongation and torsades de pointes may occur. Treatment is supportive; there is no specific antidote. Gastric lavage may be considered if ingestion was recent. Monitor ECG and electrolytes in symptomatic patients. Provide symptomatic care for gastrointestinal distress. Hemodialysis is not effective for removal.
Storage
Store Ilosone tablets and suspension at room temperature (15–30°C or 59–86°F). Keep in the original container, tightly closed, and protect from light and moisture. Do not freeze the oral suspension. Keep out of reach of children and pets. Discard any unused suspension after the expiration date or 14 days after reconstitution, whichever comes first. Do not flush medications; dispose of unused drugs via a take-back program or following local guidelines.
Disclaimer
This information is for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting or changing any medication regimen. Do not disregard or delay seeking medical advice based on content herein. The manufacturer and publisher are not liable for any outcome resulting from the use or misuse of this information.
Reviews
Clinical studies and decades of use support Ilosone’s efficacy in treating susceptible bacterial infections. It is particularly valued as an alternative for penicillin-allergic patients. Some reviews note gastrointestinal side effects as a common drawback, though these are often manageable. Hepatotoxicity, while a concern with prolonged use or in susceptible individuals, is relatively rare. Overall, it remains a trusted option in the macrolide class for appropriate indications.